MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis

(2015)   Oncotarget

Interaction between MYC and MCL1 in the Genesis and Outcome of Non-Small-Cell Lung Cancer

(2011) T. D. Allen et al.   CANCER RESEARCH

MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion

(2010) Hui-Ju Wang et al.   EUROPEAN JOURNAL OF CANCER

The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2

(2009) J. M. Friedman et al.   CANCER RESEARCH

MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity

(2009) H. Su et al.   CANCER RESEARCH

MicroRNAs: Novel Biomarkers for Human Cancer

(2009) C. L. Bartels et al.   CLINICAL CHEMISTRY

Role of miRNAs in lung cancer

(2009) William CS Cho   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells

(2008) Antonio Strillacci et al.   EXPERIMENTAL CELL RESEARCH

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

(2008) S. Varambally et al.   SCIENCE